The solution is designed to accelerate kinase activity detection and high-throughput kinase inhibitor screening
Sino Biological has launched its SwiftFluo TR-FRET Kinase Assay Kits, a ready-to-use solution designed to accelerate kinase activity detection and high-throughput kinase inhibitor screening.
“We are excited to introduce SwiftFluo TR-FRET kits as a powerful tool for the global research community,” said Sino Biological general manager Dr Jie Zhang. “These kits are thoughtfully designed to balance ease of use, cost efficiency, and reproducible data, which are critical requirements for successful high-throughput screening campaigns.”
Using Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology, the kits offer sensitivity, low background and reproducibility. This enables rapid, reliable, and scalable screening of kinase inhibitors better than traditional methods such as radioactive assays, ELISA, and fluorescence intensity-based techniques.
“Researchers can perform homogeneous, no-wash assays in a simple add-and-read format compatible with standard HTS platforms, eliminating assay development time and streamlining workflows,” said Sino Biological chief business officer Dr Rob Burgess.
The SwiftFluo TR-FRET kits provide coverage across key signalling pathways, profiling more than 60 tyrosine kinases (TKs), 150 serine/threonine kinases (STKs), and 15 cyclin-dependent kinases (CDKs).
In addition to kits, Sino Biological offers related substrates and all corresponding biologically active kinases as standalone products for custom assay design.
